Atănăsoie, A.-M.; Ancuceanu, R.V.; Krajnović, D.; Waszyk-Nowaczyk, M.; Skotnicki, M.; Tondowska, D.; Petrova, G.; Niculae, A.M.; Tăerel, A.-E.
Approved and Commercialized Antidiabetic Medicines (Excluding Insulin) in Seven European Countries—A Cross-Sectional Comparison. Pharmaceuticals 2024, 17, 793.
https://doi.org/10.3390/ph17060793
AMA Style
Atănăsoie A-M, Ancuceanu RV, Krajnović D, Waszyk-Nowaczyk M, Skotnicki M, Tondowska D, Petrova G, Niculae AM, Tăerel A-E.
Approved and Commercialized Antidiabetic Medicines (Excluding Insulin) in Seven European Countries—A Cross-Sectional Comparison. Pharmaceuticals. 2024; 17(6):793.
https://doi.org/10.3390/ph17060793
Chicago/Turabian Style
Atănăsoie, Ana-Maria, Robert Viorel Ancuceanu, Dušanka Krajnović, Magdalena Waszyk-Nowaczyk, Marcin Skotnicki, Dorota Tondowska, Guenka Petrova, Andrei Marian Niculae, and Adriana-Elena Tăerel.
2024. "Approved and Commercialized Antidiabetic Medicines (Excluding Insulin) in Seven European Countries—A Cross-Sectional Comparison" Pharmaceuticals 17, no. 6: 793.
https://doi.org/10.3390/ph17060793
APA Style
Atănăsoie, A.-M., Ancuceanu, R. V., Krajnović, D., Waszyk-Nowaczyk, M., Skotnicki, M., Tondowska, D., Petrova, G., Niculae, A. M., & Tăerel, A.-E.
(2024). Approved and Commercialized Antidiabetic Medicines (Excluding Insulin) in Seven European Countries—A Cross-Sectional Comparison. Pharmaceuticals, 17(6), 793.
https://doi.org/10.3390/ph17060793